Related Experiment Video
Updated: Mar 24, 2026

07:43
In Vivo Quantification of Hip Arthrokinematics during Dynamic Weight-bearing Activities using Dual Fluoroscopy
Published on: July 2, 2021
3.7K
SnapShot: Key Advances in hiPSC Disease Modeling
Valeria Orlova1, Christine Mummery1
1Department of Anatomy and Embryology, Leiden University Medical Centre, Einthovenweg 20, 2333ZC Leiden, The Netherlands.
Cell Stem Cell
|March 5, 2016
Summary
This review highlights advances in directed differentiation and disease modeling with human pluripotent stem cells. It showcases progress from specific cell types to complex tissue models for drug discovery and therapeutics.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Disease modeling
Background:
- Human pluripotent stem cells (hPSCs) offer a powerful platform for studying human development and disease.
- Directed differentiation protocols enable the generation of specific cell types from hPSCs.
- Advancements in hPSC technology have revolutionized disease modeling and therapeutic strategies.
Observation:
- This SnapShot visualizes the timeline of key breakthroughs in directed differentiation and disease modeling using hPSCs.
- Progress spans from generating tissue-specific hPSC derivatives to creating complex, self-organizing tissue structures.
- Color-coding in the timeline differentiates various biological systems and research advancements.
Findings:
- Key advances include the development of disease- and tissue-specific induced pluripotent stem cell (iPSC) derivatives.
- Significant progress has been made in creating robust disease models for drug screening and therapeutic development.
- Complex systems mimicking native tissue architecture and self-organized structures are increasingly being generated.
Implications:
- These advancements pave the way for personalized medicine and novel therapeutic interventions.
- Improved disease models facilitate a deeper understanding of pathological mechanisms.
- The development of complex organoid systems holds promise for regenerative medicine and drug testing.

